Lack of Better Infrastructure and Healthcare Facilities Dampens Adoption of Cytology and HPV Testing

The competitive landscapes of the cytology testing market and the human papillomavirus (HPV) testing market are both oligopolistic in nature. Transparency Market Research has found that a handful of large companies have been enjoying dominance over the global scenario, thereby reducing the level of competition and making the entry of new players extremely difficult.

Qiagen N.V., Hologic, Inc., and F.Hoffman-La Roche AG together enjoy a massive 86% of the HPV testing market. “Considering that the market shares of the first and second place companies catering to the demand for HPV testing are rather close, upcoming approvals for new screening tests are likely to have a significant impact on their position in the market,” the author of the study states. For instance, the 2014 approval of Roche’s cobas HPV test by the U.S. Food and Drug Administration (FDA) has resulted in the upsurge of the company’s market share from what it was a couple of years ago.

Similarly, Hologic and Becton Dickinson account for 89% of the cytology testing market. The only competition observed by TMR in this area of the market is currently in the segment of Pap tests in the U.S., which is a lucrative avenue for cytology testing. However, non-FDA approved tests also pose a threat to the present status of players.

“Companies in the overall cytology and HPV testing market have been relying on international expansions and collaborations to retain their dominance,” the analyst states. Direct engagement with diagnostic laboratories and contracting with governments for patient care programs are also a few key strategies adopted by the players.

Browse Global Strategic Business Report: https://goo.gl/qIraiA

Disparate Levels of Awareness among Patients Regarding Cytology and HPV Testing

The growing incidence of cervical cancer as well as HPV infections is the single most important factor driving the demand for cytology and HPV testing. The number of new cases of cervical cancer and the number of deaths resulting from this chronic condition have propelled patients to opt for early detection and diagnosis methods. The rise in awareness about the commercial availability of screening tests has driven the adoption of cytology testing. The high incidence rate of HPV infections and growing awareness regarding the threat that these infections pose to the immune system have fueled HPV testing and Pap smear screening.

However, TMR has observed that several emerging markets present a similar challenge. “The lack of access to better healthcare and infrastructure for women and the presence of outdated facilities in most developing countries restrict the large-scale adoption of cytology and HPV testing,” the analyst states.

Cytology and HPV Testing Services to Continue Leading Streak

The global market for cytology and HPV testing is projected to expand at a rapid pace over the coming years, with the value rising from US$7.9 bn in 2015 to US$10.5 bn by 2024. North America is the largest as well as the fastest expanding regional market in terms of revenue and this segment is poised to develop at a 3.3% CAGR during the forecast period to reach US$5.8 bn by 2024. While HPV testing services dominate the HPV testing market by revenue, assays kits are anticipated to register the highest CAGR of 10.1% from 2016 to 2024. On the other hand, the cytology testing market is led by cytology testing services and cytology testing assay kits are likely to expand at a 5.1% CAGR, the fastest among other sub-segments.

This review is based on the findings of a TMR report titled “Cytology and HPV Testing: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015-2023.”

Global Cytology and HPV Testing Market, by Product and Services

Cytology Testing
Systems
Assay Kits
Services
HPV Testing
Systems
Assay Kits
Services
Global Cytology and HPV Testing Market, by Geography

North America
U.S.
Canada
Europe
Germany
France
U.K.
Rest of Europe
Asia Pacific
Japan
China
Australia
Rest of APAC
Rest of the World (RoW)
Brazil
Mexico
Rest of RoW
Download Exclusive Brochure of This Report : https://goo.gl/8oKuKL

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com

This release was published on openPR.